Matches in SemOpenAlex for { <https://semopenalex.org/work/W3182078637> ?p ?o ?g. }
- W3182078637 endingPage "e0253492" @default.
- W3182078637 startingPage "e0253492" @default.
- W3182078637 abstract "This meta-analysis aimed to summarize the available evidence to compare angiotensin-converting enzyme (ACE) inhibitors with angiotensin II receptor blockers (ARBs) on improving insulin sensitivity in hypertensive patients.Randomized controlled trials (RCTs) comparing ACE inhibitors versus ARBs published with outcomes on homeostasis model assessment of IR (HOMA-IR), glucose infusion rate (GIR), the quantitative insulin sensitivity check index (QUICKI), insulin sensitivity index (ISI) composite, fasting plasma glucose (FPG), fasting plasma insulin (FPI), systolic blood pressure (SBP), and diastolic blood pressure (DBP) were searched through 5 databases. Data were searched from their inception to July 5, 2020. Stata 14.0 was used to perform the meta-analysis.Eleven RCTs (n = 1015) were included in this meta-analysis. Pooled analysis of studies showed no significant difference in HOMA-IR between ARBs and ACE inhibitors (WMD = -0.09, 95% CI: -0.69 to 0.50, P = 0.755); however, subgroup analysis of therapeutic duration showed a significant difference in HOMA-IR between ARBs and ACE inhibitors among the long-term intervention subgroup (>12 weeks) (WMD = 0.41, 95% CI: 0.06 to 0.76, P = 0.022) and hypertensive patients with diabetes mellitus subgroup (WMD = 0.55, 95% CI: 0.49 to 0.61, P < 0.001); results showed no significant difference between ARBs and ACE inhibitors on QUICKI score (WMD = -0.00, 95% CI: -0.03 to 0.03, P = 0.953) in hypertensive patients; however, the efficacy of ACE inhibitors on improving GIR and ISI composite was significantly better than that of ARBs (WMD = -1.09, 95% CI: -1.34 to -0.85, P < 0.001; WMD = -0.80, 95% CI: -1.24 to -0.36, P < 0.001, respectively). Furthermore, no significant differences were noted on FPG (WMD = 0.72, 95% CI: -1.39 to 2.83, P = 0.505), FPI (WMD = -0.48, 95% CI: -1.60 to 0.64, P = 0.398), SBP (WMD = -0.65, 95% CI: -1.76 to 0.46, P = 0.254), and DBP (WMD = -0.30, 95% CI: -1.70 to 1.10, P = 0.675) between ARBs and ACE inhibitors.Results from this meta-analysis showed that ACE inhibitors resulted in more effective improvement of HOMA-IR compared with ARBs among the long-term intervention and hypertensive patients with DM subgroup; furthermore, the efficacy of ACE inhibitors on improving GIR and ISI composite was significantly better than that of ARBs in hypertensive patients. However, ARBs had no significant difference in QUICKI score, FPG, FPI, SBP, and DBP compared with ACE inhibitors. Larger and better-designed studies are needed to further verify this conclusion." @default.
- W3182078637 created "2021-07-19" @default.
- W3182078637 creator A5007128842 @default.
- W3182078637 creator A5022471420 @default.
- W3182078637 creator A5023045511 @default.
- W3182078637 creator A5056419904 @default.
- W3182078637 creator A5080745747 @default.
- W3182078637 creator A5087334358 @default.
- W3182078637 date "2021-07-07" @default.
- W3182078637 modified "2023-10-01" @default.
- W3182078637 title "Angiotensin-converting enzyme inhibitors versus angiotensin II receptor blockers on insulin sensitivity in hypertensive patients: A meta-analysis of randomized controlled trials" @default.
- W3182078637 cites W1981670919 @default.
- W3182078637 cites W1989071951 @default.
- W3182078637 cites W1991588580 @default.
- W3182078637 cites W2009696389 @default.
- W3182078637 cites W2023531846 @default.
- W3182078637 cites W2024214080 @default.
- W3182078637 cites W2026078677 @default.
- W3182078637 cites W2032422942 @default.
- W3182078637 cites W2038299461 @default.
- W3182078637 cites W2041265746 @default.
- W3182078637 cites W2059104720 @default.
- W3182078637 cites W2091596600 @default.
- W3182078637 cites W2093601391 @default.
- W3182078637 cites W2105652793 @default.
- W3182078637 cites W2111687178 @default.
- W3182078637 cites W2113273743 @default.
- W3182078637 cites W2115742160 @default.
- W3182078637 cites W2120336033 @default.
- W3182078637 cites W2124610904 @default.
- W3182078637 cites W2126125759 @default.
- W3182078637 cites W2126327417 @default.
- W3182078637 cites W2141230364 @default.
- W3182078637 cites W2143104968 @default.
- W3182078637 cites W2143722118 @default.
- W3182078637 cites W2149420140 @default.
- W3182078637 cites W2156121263 @default.
- W3182078637 cites W2164632621 @default.
- W3182078637 cites W2168992993 @default.
- W3182078637 cites W2434078654 @default.
- W3182078637 cites W2521653101 @default.
- W3182078637 cites W2895179414 @default.
- W3182078637 cites W2898669007 @default.
- W3182078637 cites W3023402812 @default.
- W3182078637 cites W4235479662 @default.
- W3182078637 cites W4252272548 @default.
- W3182078637 cites W63288844 @default.
- W3182078637 doi "https://doi.org/10.1371/journal.pone.0253492" @default.
- W3182078637 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8263258" @default.
- W3182078637 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34234365" @default.
- W3182078637 hasPublicationYear "2021" @default.
- W3182078637 type Work @default.
- W3182078637 sameAs 3182078637 @default.
- W3182078637 citedByCount "3" @default.
- W3182078637 countsByYear W31820786372023 @default.
- W3182078637 crossrefType "journal-article" @default.
- W3182078637 hasAuthorship W3182078637A5007128842 @default.
- W3182078637 hasAuthorship W3182078637A5022471420 @default.
- W3182078637 hasAuthorship W3182078637A5023045511 @default.
- W3182078637 hasAuthorship W3182078637A5056419904 @default.
- W3182078637 hasAuthorship W3182078637A5080745747 @default.
- W3182078637 hasAuthorship W3182078637A5087334358 @default.
- W3182078637 hasBestOaLocation W31820786371 @default.
- W3182078637 hasConcept C126322002 @default.
- W3182078637 hasConcept C134018914 @default.
- W3182078637 hasConcept C168563851 @default.
- W3182078637 hasConcept C187960798 @default.
- W3182078637 hasConcept C27016395 @default.
- W3182078637 hasConcept C2777391703 @default.
- W3182078637 hasConcept C2778901321 @default.
- W3182078637 hasConcept C2779306644 @default.
- W3182078637 hasConcept C2908929049 @default.
- W3182078637 hasConcept C3017594256 @default.
- W3182078637 hasConcept C555293320 @default.
- W3182078637 hasConcept C71924100 @default.
- W3182078637 hasConcept C84393581 @default.
- W3182078637 hasConcept C95190672 @default.
- W3182078637 hasConceptScore W3182078637C126322002 @default.
- W3182078637 hasConceptScore W3182078637C134018914 @default.
- W3182078637 hasConceptScore W3182078637C168563851 @default.
- W3182078637 hasConceptScore W3182078637C187960798 @default.
- W3182078637 hasConceptScore W3182078637C27016395 @default.
- W3182078637 hasConceptScore W3182078637C2777391703 @default.
- W3182078637 hasConceptScore W3182078637C2778901321 @default.
- W3182078637 hasConceptScore W3182078637C2779306644 @default.
- W3182078637 hasConceptScore W3182078637C2908929049 @default.
- W3182078637 hasConceptScore W3182078637C3017594256 @default.
- W3182078637 hasConceptScore W3182078637C555293320 @default.
- W3182078637 hasConceptScore W3182078637C71924100 @default.
- W3182078637 hasConceptScore W3182078637C84393581 @default.
- W3182078637 hasConceptScore W3182078637C95190672 @default.
- W3182078637 hasIssue "7" @default.
- W3182078637 hasLocation W31820786371 @default.
- W3182078637 hasLocation W31820786372 @default.
- W3182078637 hasLocation W31820786373 @default.
- W3182078637 hasLocation W31820786374 @default.
- W3182078637 hasOpenAccess W3182078637 @default.
- W3182078637 hasPrimaryLocation W31820786371 @default.